查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年北美微载体市场预测 - 区域分析 - 按产品、设备、应用和最终用户
市场调查报告书
商品编码
1494453

到 2030 年北美微载体市场预测 - 区域分析 - 按产品、设备、应用和最终用户

North America Microcarriers Market Forecast to 2030 - Regional Analysis - by Product, Equipment, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 89 Pages | 订单完成后即时交付

价格

北美微载体市场预计将从2022年的7.3667亿美元成长到2030年的19.3356亿美元。

细胞和基因治疗製造服务的自动化推动了北美微载体市场

在细胞和基因治疗製造中纳入自动化将降低污染风险、提高一致性并降低生产成本。 Lonza Cocoon 和 Miltenyi 的 CliniMACS Prodigy 系统是市场上现有的一些设备，这些设备旨在实现单一系统内 CAR-T 流程的大多数顺序单元操作的自动化。对细胞和基因疗法不断增长的需求已将全球范围内的生产从小批量製程转向大批量製程。细胞和基因疗法从学术和临床环境到大规模生产和商业化的进展进一步推动了商业製造对自动化的需求。 2020 年 7 月，Thermo Fisher Scientific Inc. 和 Lyell Nutrition 合作开发流程，为癌症患者设计有效的细胞疗法。根据这项合作关係，两家公司的目标是提高 T 细胞的能力，并支持开发符合现行良好生产规范 (cGMP) 的综合平台（系统和软体）以及试剂、耗材和仪器。此外，美国政府援助的组织正在细胞疗法的製造中采用自动化，以提高该国的国家生产能力。因此，自动化正在成为微载体市场的新趋势。

北美微载体市场概况

北美微载体市场分为美国、加拿大和墨西哥。美国在该地区市场占据主导地位。北美微载体市场的成长归因于生物技术和生物製药公司推出的产品数量不断增加、主要市场参与者的存在以及各个学术和研究机构的广泛研发。慢性病盛行率的上升是推动美国微载体市场成长的主要因素。根据美国疾病管制与预防中心 (CDC) 的数据，十分之六的美国人患有至少一种慢性疾病，例如心臟病、中风、癌症或糖尿病。这些疾病是美国死亡和残疾的重要原因，而且还导致巨大的医疗费用。细胞和基因疗法（CGT）领域取得了广泛的临床进展，因此这些疗法的应用范围在过去5年中不断扩大。在 2016 年至 2021 年的分析期间，随着 12 种新疗法的批准和超过 2,900 项临床试验的启动，CGT 创新得到了广泛的投资。基因编辑技术的进步，以及评估此技术治疗效果的临床试验，是有利于美国微载体市场的其他因素。例如，Poseida Therapeutics, Inc. 的P-CD19CD20-ALLO1 的研究性新药(IND) 申请获得美国食品和药物管理局(FDA) 批准，这是该公司首款同时靶向CD19 和CD19 的同种异体双CAR-T 细胞候选产品。 2023 年 4 月，新型同种异体 CAR T 细胞疗法在转移性透明细胞肾细胞癌患者中取得了成果。因此，增加临床试验的参与和投资可以加速新疗法的采用和可用性。德州大学MD 安德森癌症中心的研究人员领导了I 期试验，并在美国癌症研究协会(AACR) 2023 年年会上进行了报告。 , Inc. 宣布对支持 Poseida 重新定义癌细胞疗法的承诺。安斯泰来投资 5000 万美元获得 Poseida 一项临床阶段计画的许可，该计画专注于 P-MUC1C-ALLO1，这是一种用于多种实体瘤适应症的同种异体 CAR T 细胞疗法。因此，随着慢性病病例数量的增加以及不同细胞和基因疗法的批准，美国对微载体的需求正在增加。

北美微载体市场营收及 2030 年预测（百万美元）

北美微载体市场细分

北美微载体市场分为产品、设备、应用、最终用户和国家。

根据产品，北美微载体市场分为微载体珠和培养基和试剂。 2022 年，微载体珠细分市场在北美微载体市场中占有更大份额。

在设备方面，北美微载体市场分为生物反应器、培养皿等。 2022 年，生物反应器领域占据北美微载体市场的最大份额。

根据应用，北美微载体市场分为生物製药生产、细胞和基因治疗、组织工程和再生医学等。 2022年，生物製药生产领域在北美微载体市场中占据最大份额。

根据最终用户，北美微载体市场分为製药和生物技术公司、合约研究组织和合约製造组织以及学术和研究机构。 2022 年，製药和生物技术公司领域占据北美微载体市场的最大份额。

根据国家/地区，北美微载体市场分为美国、加拿大和墨西哥。 2022 年，美国主导北美微载体市场。

Teijin Ltd、Bio-Rad Laboratories Inc、Sartorius AG、Danaher Corp、Corning Inc、Eppendorf SE、Asahi Kasei Corp 和 Polysciences Inc 是北美微载体市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美微载体市场 - 主要产业动态

  • 主要市场驱动因素：
    • 随着癌症和传染病发病率的上升，对细胞疗法的需求
    • 外包细胞和基因治疗製造越来越受欢迎
    • 再生医学的采用激增
  • 市场限制
    • 生物製剂和细胞疗法的高成本
  • 市场机会
    • 微载体製造商的策略性倡议和创新产品
  • 未来的趋势
    • 细胞和基因治疗製造服务的自动化
  • 影响分析

第 5 章：微载体市场 - 北美市场分析

  • 微载体市场收入，2022 - 2030

第 6 章：北美微载体市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年按产品分類的微载体市场收入份额 (%)
  • 微载体珠
  • 介质和试剂

第 7 章：北美微载体市场 - 收入和 2030 年预测 - 按设备

  • 概述
  • 2022 年及 2030 年按设备分類的微载体市场收入份额 (%)
  • 生物反应器
  • 培养容器
  • 其他的

第 8 章：北美微载体市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年和 2030 年按应用分類的微载体市场收入份额 (%)
  • 生物製药生产
  • 细胞和基因治疗
  • 组织工程与再生医学
  • 其他的

第 9 章：北美微载体市场收入和 2030 年预测 - 最终用户

  • 概述
  • 北美微载体最终用户市场占有率 - 2022 年和 2030 年 (%)
  • 製药和生物技术公司
    • 概述
    • 製药和生物技术公司：微载体市场 - 收入和 2030 年预测
  • 合约研究组织和合约製造组织
    • 概述
    • 合约研究组织和合约製造组织：微载体市场 - 收入和 2028 年预测
  • 学术及研究机构
    • 概述
    • 学术和研究机构：微载体市场 - 收入和 2028 年预测

第 10 章：北美微载体市场收入和 2030 年预测 - 国家分析

    • 北美洲
      • 我们
      • 加拿大
      • 墨西哥

第 11 章：微载体市场-产业格局

  • 概述
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Asahi Kasei Corp
  • Polysciences Inc

第 13 章：附录

Product Code: BMIRE00029976

The North America microcarriers market is expected to grow from US$ 736.67 million in 2022 to US$ 1,933.56 million by 2030. It is estimated to record a CAGR of 12.8% from 2022 to 2030.

Automation of Cell and Gene Therapy Manufacturing Services Fuels North America Microcarriers Market

Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. In July 2020, Thermo Fisher Scientific Inc. and Lyell Immunopharma partnered to develop processes to design effective cell therapies for cancer patients. Under this partnership, the companies aim to improve the capability of T-cells and support the development of an integrated current good manufacturing practice (cGMP) compliant platform (system and software), along with reagents, consumables, and instruments. Further, the US government-aided organizations are adopting automation in the manufacturing of cell therapies to increase the national production capabilities of the country. Thus, automation is emerging as a new trend in the microcarriers market.

North America Microcarriers Market Overview

The North America microcarriers market is segmented into the US, Canada, and Mexico. The US dominates the market in this region. The growth of the microcarriers market in North America is attributed to the increasing number of product launches by biotechnology and biopharmaceutical companies, the presence of key market players, and extensive R&D by various academic and research institutes. The rising prevalence of chronic diseases is a leading factor propelling the growth of the microcarrier market in the US. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 Americans live with at least 1 chronic disease, such as heart disease and stroke, cancer, or diabetes. These diseases are the significant causes of mortality and disability in the US, and they also lead to significant costs of healthcare. There have been extensive clinical developments in the field of cell and gene therapies (CGT), owing to which the application range of these therapies has expanded in the past 5 years. With the approval of 12 new therapies and the commencement of over 2,900 clinical trials during the analysis period of 2016-2021, there have been extensive investments in CGT innovations. Technological advancements in gene editing, followed by clinical trials to evaluate the therapeutic effectiveness of the technique, are the other factors that have benefitted the microcarriers market in the US. For example, Poseida Therapeutics, Inc. received the US Food and Drug Administration (FDA) approval for its Investigational New Drug (IND) application for P-CD19CD20-ALLO1-the company's first allogeneic dual CAR-T cell product candidate targeting both CD19 and CD20 antigens for the treatment of relapsed or refractory B-cell malignancies-being developed in partnership with Roche. In April 2023, Novel allogeneic CAR T-cell therapy delivered results in patients with metastatic clear cell renal cell carcinoma. Thus, increased participation and investments in clinical trials can accelerate the adoption and availability of new therapies. Researchers at the University of Texas MD Anderson Cancer Center led the Phase I trial and presented at the American Association for Cancer Research (AACR) Annual Meeting 2023. In August 2023, Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy. Astellas invested US$ 50 million to license one of Poseida's clinical-stage programs focusing on P-MUC1C-ALLO1, an allogeneic CAR T-cell therapy for multiple solid tumor indications. Thus, the demand for microcarriers is on the rise in the US with the increasing number of chronic disease cases and approval of different cell and gene therapies.

North America Microcarriers Market Revenue and Forecast to 2030 (US$ Million)

North America Microcarriers Market Segmentation

The North America microcarriers market is segmented into product, equipment, application, end user, and country.

Based on product, the North America microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held a larger share of the North America microcarriers market in 2022.

In terms of equipment, the North America microcarriers market is segmented into bioreactors, culture vessels, and others. The bioreactors segment held the largest share of the North America microcarriers market in 2022.

Based on application, the North America microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production segment held the largest share of the North America microcarriers market in 2022. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the North America microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held the largest share of the North America microcarriers market in 2022.

Based on country, the North America microcarriers market is segmented into the US, Canada, and Mexico. The US dominated the North America microcarriers market in 2022.

Teijin Ltd, Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc are some of the leading companies operating in the North America microcarriers market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Microcarriers Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
    • 4.1.3 Surge in Adoption of Regenerative Medicine
  • 4.2 Market Restraints
    • 4.2.1 High Cost of Biologics and Cell-based Therapies
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 4.4 Future Trends
    • 4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 4.5 Impact Analysis

5. Microcarriers Market - North America Market Analysis

  • 5.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

6. North America Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 6.1 Overview
  • 6.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 Microcarrier Beads
    • 6.3.1 Overview
    • 6.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Media and Reagents
    • 6.4.1 Overview
    • 6.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 7.3 Bioreactors
    • 7.3.1 Overview
    • 7.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Culture Vessels
    • 7.4.1 Overview
    • 7.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Biopharmaceutical Production
    • 8.3.1 Overview
    • 8.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Cell and Gene Therapy
    • 8.4.1 Overview
    • 8.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Tissue Engineering and Regenerative Medicine
    • 8.5.1 Overview
    • 8.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 9.1 Overview
  • 9.2 North America Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Overview
    • 9.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 9.4.1 Overview
    • 9.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

10. North America Microcarriers Market Revenue and Forecasts to 2030 - Country Analysis

  • 10.1 North America Microcarriers Market, Revenue and Forecast To 2030
    • 10.1.1 Overview
    • 10.1.2 North America: Microcarriers Market, by Country
      • 10.1.2.1 US
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 US: Microcarriers Market, by Product
        • 10.1.2.1.4 US: Microcarriers Market, by Equipment
        • 10.1.2.1.5 US: Microcarriers Market, by Application
        • 10.1.2.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.1.6 US: Microcarriers Market, by End User
      • 10.1.2.2 Canada
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Canada: Microcarriers Market, by Product
        • 10.1.2.2.4 Canada: Microcarriers Market, by Equipment
        • 10.1.2.2.5 Canada: Microcarriers Market, by Application
        • 10.1.2.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.2.6 Canada: Microcarriers Market, by End User
      • 10.1.2.3 Mexico
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Mexico: Microcarriers Market, by Product
        • 10.1.2.3.4 Mexico: Microcarriers Market, by Equipment
        • 10.1.2.3.5 Mexico: Microcarriers Market, by Application
        • 10.1.2.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
        • 10.1.2.3.6 Mexico: Microcarriers Market, by End User

11. Microcarriers Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Growth Strategies
    • 11.2.1 Overview
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Teijin Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Bio-Rad Laboratories Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Sartorius AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Corning Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Eppendorf SE
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Asahi Kasei Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Polysciences Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. US Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. US Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. US Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. US Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. Canada Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. Canada Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. Canada Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. Canada Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. Mexico Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Mexico Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. Mexico Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. Mexico Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Recent Organic Growth Strategies in Microcarriers Market
  • Table 18. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 19. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Country
  • Figure 2. Key Insights
  • Figure 3. Microcarriers Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 5. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 10. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 22. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Microcarriers Market, 2022 (US$Mn)
  • Figure 25. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 26. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)